Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis
- 1 August 2014
- journal article
- Published by Elsevier in Metabolism
- Vol. 63 (8) , 1041-1048
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Silencing of FGF‐21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3–SOCS3 signalThe FEBS Journal, 2014
- Liver-Enriched Transcription Factor CREBH Interacts With Peroxisome Proliferator-Activated Receptor α to Regulate Metabolic Hormone FGF21Endocrinology, 2014
- The human sirtuin family: Evolutionary divergences and functionsHuman Genomics, 2011
- FGFs and metabolismCurrent Opinion in Pharmacology, 2009
- The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid MetabolismCurrent Diabetes Reviews, 2009
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese MiceDiabetes, 2009
- Endocrine fibroblast growth factors as regulators of metabolic homeostasisBioFactors, 2009
- PPARα is a key regulator of hepatic FGF21Biochemical and Biophysical Research Communications, 2007
- Sirtuins in mammals: insights into their biological functionBiochemical Journal, 2007
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005